Anti-Counterfeit Technologies: A Pharmaceutical Industry Perspective

Dipika Bansal

Open source

DOI
10.3797/scipharm.1202-03
Published
2013
Container
Scientia Pharmaceutica
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3797/scipharm.1202-03,
  title = {Anti-Counterfeit Technologies: A Pharmaceutical Industry Perspective},
  author = {Dipika Bansal},
  year = {2013},
  journal = {Scientia Pharmaceutica},
  doi = {10.3797/scipharm.1202-03},
  url = {https://doi.org/10.3797/scipharm.1202-03}
}

RIS

TY  - JOUR
TI  - Anti-Counterfeit Technologies: A Pharmaceutical Industry Perspective
AU  - Dipika Bansal
PY  - 2013
JO  - Scientia Pharmaceutica
DO  - 10.3797/scipharm.1202-03
UR  - https://doi.org/10.3797/scipharm.1202-03
ER  - 

APA

Bansal, D. (2013). Anti-Counterfeit Technologies: A Pharmaceutical Industry Perspective. Scientia Pharmaceutica. https://doi.org/10.3797/scipharm.1202-03

Source records